Alexia Belavgeni

1.2k citations
14 papers · 696 indexed · h-index 10
Topics
Ferroptosis and cancer prognosis (4 papers)Inflammasome and immune disorders (3 papers)Heme Oxygenase-1 and Carbon Monoxide (3 papers)

In The Last Decade

Alexia Belavgeni

13 papers receiving 694 citations

Peers

Alexia Belavgeni
Comparison fields: 5 of 104
  • Molecular Biology 365
  • Pulmonary and Respiratory Medicine 256
  • Cancer Research 198
  • Immunology 88
  • Nephrology 84
Replace Wen Xia with:
Wen Xia China
Seok-Jo Kim South Korea
Xianlei Cai China
Yanfeng Zhao China
Qixing Zhu China
Ken Kawamura Japan
Jiahao Zhang China
Briana K. Shimada United States
Hae‐Ryung Park United States
Xuyan He China
Alexia Belavgeni relative to Wen Xia China Wen Xia's profile →
Citations per field
00.5×1.5×
Wen Xia · 1×
Citations per year

Countries citing papers authored by Alexia Belavgeni

Since Specialization
Citations

This map shows the geographic impact of Alexia Belavgeni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexia Belavgeni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexia Belavgeni more than expected).

Fields of papers citing papers by Alexia Belavgeni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexia Belavgeni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexia Belavgeni. The network helps show where Alexia Belavgeni may publish in the future.

Co-authorship network of co-authors of Alexia Belavgeni

This figure shows the co-authorship network connecting the top 25 collaborators of Alexia Belavgeni. A scholar is included among the top collaborators of Alexia Belavgeni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexia Belavgeni. Alexia Belavgeni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 0
2 1
3 78
4 35
5 4
6 50
7 10
8 213
9 82
10 132
11 29
12 19
13 8
14 35

About Alexia Belavgeni

Alexia Belavgeni is a scholar working on Nephrology, Health, Toxicology and Mutagenesis and Pollution, having authored 14 papers that have together received 696 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (4 papers), Inflammasome and immune disorders (3 papers) and Heme Oxygenase-1 and Carbon Monoxide (3 papers). The work is most often cited by research in Cancer Research (198 citations), Nephrology (84 citations) and Pulmonary and Respiratory Medicine (256 citations). Alexia Belavgeni has collaborated with scholars based in Germany, United Kingdom and Greece. Frequent co-authors include Andreas Linkermann, Christian Hugo, Claudia Meyer, Julian Stumpf, Wulf Tonnus, Stefan R. Bornstein, Anne von Mäßenhausen, Stefanos Dailianis, Jan U. Becker and Alexander Paliege. Their work appears in journals such as Proceedings of the National Academy of Sciences, Analytical Chemistry and Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026